PhD Candidate at UCL Science, Technology, Engineering and Public Policy, UCL
BSc Imperial College London - Biochemistry/Biotechnology (First Class Hons)
MPhil University of Cambridge (Darwin College) - Computational Biology
PhD Candidate at STEaPP UCL
My PhD is focused on developing public policy frameworks for the introduction of germline genome editing technologies into the UK.
The end goal is to form the largest biobank of qualitative research in the UK on these matters.
Associate Consultant, Atheneum Partners London
(08/2019 – Present)
- Part of the research/strategy consulting team working with blue-chip clients across several industries including Healthcare & Pharma, Utilities (Electricity), Petrochemicals and Polymers, FMCG and Construction Engineering. Focus Geographies: EMEA and North America.
- Currently support clients with: Market entry, M&A target identification, Competitor intelligence-benchmarking, 'Voice of Customer' insights and Supply Chain Mapping.
- Produce actionable outputs and deliverables frequently presented at board level.
Apr 30, 2021 07:50 am UTC| Technology
The UK government recently announced an 800 million, taxpayer-funded Advanced Research and Invention Agency (Aria). The brainchild of the British prime ministers former chief adviser, Dominic Cummings and modelled on the...